IBC Life Sciences

New Online Partnering System Information

All attendees of this conference will receive access to our new online partnering system before, during and after the event.

Log in information will be sent to you via email shortly after you have completed the registration process. After receiving your username, you may log in here

Keynote Presentations

Biotech 2010 Life Science: Adapting for Success

G. Steven Burrill
Chief Executive Officer
Burrill & Company

Industrialization of mAb Production - Implications, Challenges and Opportunities

Dana Andersen, Ph.D.
Senior Director, Process R&D Oceanside, Operations & Engineering
Genentech, Inc.

Featured Presentations

Battling the Biological and Biochemical Challenges to Efficient Upstream/Downstream Process Integration

Robert D. Kiss, Ph.D.
Director, Late Stage Cell Culture,Process R&D
Genentech, Inc.

Improving Bulk Process Transfer at Centocor: The 'Process-Fit-to-Plant' Program

Charles F. Goochee, Ph.D.
Fellow, CMC Strategy, Large Molecule, Portfolio Management and Technical Integration
J&J/Centocor

PLUS! - Upstream and Downstream Process Development Using a QbD Approach - Results from the CMC Biotech Working Group

Victor A. Vinci, Ph.D.
Director, Bioprocess Operations, Bioproduct R&D
Eli Lilly and Company

Amit Banerjee, Ph.D.
Research Fellow, Global Biologics
Pfizer Inc.

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

Antibody Development & Production is regarded as the most comprehensive event that delivers industry best practices across the spectrum of upstream and downstream processing. Take advantage of early registration discounts by securing your seat today.

We invite you to join us on March 3-5 for this comprehensive 3Day program that will allow you to:

• Evaluate the next generation technologies and processes that will further optimize cell culture
• Hear approaches to integrate manufacturability assessments early to improve expression levels and quality
• Examine the latest efforts to achieve process integration at the interface of upstream and downstream processing
• Learn how continuous chromatography offers substantial economic advantages for affinity protein purification
• Determine when an immunogenicity assessment is warranted
• Gain a better understanding of the impact of QbD and DOE

By attending, you will learn how companies are developing the latest molecular assessment approaches to optimize manufacturability and product quality and how they are applying smarter and faster tools for rapid process development. Industry leaders will assess the state of the industry and offer solutions to overcome the current capacity issues as they work towards their goals of lean manufacturing and facility optimization.